You will be redirected to the related website.
This information helps us optimize our content and make surfing on our site more convenient for you. In some cases, cookies are also used to make specific information about our products available on websites of other providers. This is why we also work with external service companies which use the information obtained from cookies exclusively for this purpose.
The information obtained from cookies is not used for any further purpose.
You can adjust the settings on your browser so that you are notified whenever a server wants to send you a cookie. You can accept or reject cookies; you can also completely block them. Further information is available in the help function of your browser.
In light of the discussion about the use of Analysetools and complete IP addresses, we wish to state that this website works with Google Analytics and the "_anonymizeIp()" function; consequently, it only processes partial IP addresses so as to rule out identifying information.
You can refuse the use of Google Analytics by clicking on the following link. An opt-out cookie will be set on the computer, which prevents the future collection of your data when visiting this website: Disable Google Analytics.*
EPs® 7630 is one of the best researched plant based cough & cold medicines in the world. It features a unique mode of action that treats acute respiratory tract infections like the common cold, acute bronchitis, acute sinusitis and tonsillitis , and it is suitable for the whole family.
Unique Triple Mode of Action
EPs® 7630 is distinct from other products on the market thanks to its unique threefold mode of action:
Unlike other remedies, EPs® 7630 not only relieves cough & cold symptoms over a short period of time, but it also tackles the cause of the infection. Thus it shortens the duration of the illness and helps people to recover and feel better faster.
Dosage forms of EPs® 7630
EPs® 7630 is available in three different product forms – solution, tablets and syrup – to serve different needs. In general EPs® 7630 is suitable for adults and children from the age of one year.
Usage of EPs® 7630
Depending on the severity of the symptoms, use other medication to ease symptoms, e.g. pain relievers and decongestants.
EPs® 7630 is naturally safe and effective, and interactions with other medicinal products are generally not to be anticipated. There is no risk of developing microbial resistance.
If symptoms persist or worsen, please consult a doctor.
Special patient groups
EPs® 7630 is suitable for many special patient groups too:
Diabetics - the amount of sugar absorbed in the daily dose is diabetologically irrelevant.
Patients with coeliac disease (gluten enteropathy) – EPs® 7630 products do not contain gluten.
Children ≥1 year of age.
Patients with intolerance to lactose – solution and syrup do not contain lactose.
Vegan patients – solution and syrup do not contain animal products.
EPs® 7630 is available in over 50 countries worldwide under various brand names such as Umckaloabo®, Umcka®, Umckalor®, Kaloba®, Kaloban® and Renikan®.
» Local brands